DAVIDSON KEMPNER CAPITAL MANAGEMENT LP - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 114 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.75 and the average weighting 0.5%.

Quarter-by-quarter ownership
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$2,559,000
-62.0%
142,965
-46.7%
0.04%
-61.1%
Q3 2017$6,727,000268,0010.09%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$13,340,0009.89%
Abingworth LLP 1,041,131$5,341,0004.85%
Roumell Asset Management, LLC 450,406$2,311,0004.78%
HIGHLAND CAPITAL MANAGEMENT LP 2,391,993$12,271,0000.94%
Trellus Management Company, LLC 71,200$365,0000.82%
ARMISTICE CAPITAL, LLC 1,968,000$10,096,0000.76%
Arbiter Partners Capital Management LLC 1,111,936$5,704,0000.64%
Fortress Investment Group LLC 433,804$2,226,0000.27%
GENERAL AMERICAN INVESTORS CO INC 464,985$2,385,0000.25%
WATER ISLAND CAPITAL LLC 318,518$1,634,0000.12%
View complete list of PARATEK PHARMACEUTICALS INC shareholders